CoraLite® Plus 750 Anti-Human CD68 (Y1/82A)
CD68 Monoclonal Antibody for FC (Intra)
Host / Isotype
Mouse / IgG2b, kappa
Reactivity
Human
Applications
FC (Intra)
Conjugate
CoraLite® Plus 750 Fluorescent Dye
CloneNo.
Y1/82A
Cat no : CL750-65187
Synonyms
Validation Data Gallery
Tested Applications
Positive FC detected in | human PBMCs |
Recommended dilution
Application | Dilution |
---|---|
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 μl per 10^6 cells in a 100 µl suspension or 5 μl per 100 µl of whole blood. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL750-65187 targets CD68 in FC (Intra) applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Mouse / IgG2b, kappa |
Class | Monoclonal |
Type | Antibody |
Immunogen | Lysosomal contents of lung macrophages |
Full Name | CD68 molecule |
Calculated Molecular Weight | 37 kDa |
GenBank Accession Number | BC015557 |
Gene Symbol | CD68 |
Gene ID (NCBI) | 968 |
Conjugate | CoraLite® Plus 750 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 755 nm / 780 nm |
Form | Liquid |
Purification Method | Purified by protein-A affinity chromatography |
Storage Buffer | PBS with 0.09% sodium azide and 0.5% BSA. |
Storage Conditions | Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment. |
Background Information
CD68 is a type I transmembrane glycoprotein that is highly expressed by human monocytes and tissue macrophages. It belongs to the lysosomal/endosomal-associated membrane glycoprotein (LAMP) family and primarily localizes to lysosomes and endosomes with a smaller fraction circulating to the cell surface. CD68 is also a member of the scavenger receptor family. It may play a role in phagocytic activities of tissue macrophages.
Protocols
Product Specific Protocols | |
---|---|
FC protocol for CL Plus 750 CD68 antibody CL750-65187 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |